Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Role of pratelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice (2011)

  • Authors:
  • USP affiliated authors: CUNHA, FERNANDO DE QUEIROZ - FMRP
  • USP Schools: FMRP
  • DOI: 10.1007/s00280-010-1540-5
  • Subjects: CITOCINAS; SISTEMA GASTROINTESTINAL
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/s00280-010-1540-5 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Informações sobre o Citescore
  • Título: Cancer Chemotherapy and Pharmacology

    ISSN: 0344-5704

    Citescore - 2017: 2.91

    SJR - 2017: 1.147

    SNIP - 2017: 0.899


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FMRP2241920pcd 2241920 estantes deslizantes
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SOARES, Pedro Marcos G.; LIMA JUNIOR, Roberto César P.; MOTA, José Maurício S. C.; et al. Role of pratelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. Cancer Chemotherapy and Pharmacology, Heidelberg, v. 68, n. 3, p. 713-720, 2011. DOI: 10.1007/s00280-010-1540-5.
    • APA

      Soares, P. M. G., Lima Junior, R. C. P., Mota, J. M. S. C., Justino, P. F. C., Brito, G. A. C., Ribeiro, R. de A., et al. (2011). Role of pratelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. Cancer Chemotherapy and Pharmacology, 68( 3), 713-720. doi:10.1007/s00280-010-1540-5
    • NLM

      Soares PMG, Lima Junior RCP, Mota JMSC, Justino PFC, Brito GAC, Ribeiro R de A, Cunha F de Q, Souza MHLP de. Role of pratelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. Cancer Chemotherapy and Pharmacology. 2011 ; 68( 3): 713-720.
    • Vancouver

      Soares PMG, Lima Junior RCP, Mota JMSC, Justino PFC, Brito GAC, Ribeiro R de A, Cunha F de Q, Souza MHLP de. Role of pratelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. Cancer Chemotherapy and Pharmacology. 2011 ; 68( 3): 713-720.

    Referências citadas na obra
    Baerg J, Murphy JJ, Anderson R, Magee JF (1999) Neutropenic enteropathy: a 10-year review. J Pediatr Surg 34:1068–1071
    Borman RA, Jewell R, Hillier K (1998) Investigation of the effects of platelet-activating factor (PAF) on ion transport and prostaglandin synthesis in human colonic mucosa in vitro. Br J Pharmacol 123:231–236
    Bowen JM, Gibson RJ, Cummins AG, Keefe DM (2006) Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage. Support Care Cancer 14:713–731
    Bradley PP, Christensen RD, Rothstein G (1982) Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood 60:618–622
    Caplan MS, Hedlund E, Adler L, Lickerman M, Hsueh W (1997) The platelet-activating factor receptor antagonist WEB 2170 prevents neonatal necrotizing enterocolitis in rats. J Pediatr Gastroenterol Nutr 24:296–301
    Chao W, Liu H, Hanahan DJ, Olson MS (1192) Platelet-activating factor-stimulated protein tyrosine phosphorylation and eicosanoid synthesis in rat Kupffer cells. Evidence for calcium-dependent and protein kinase C-dependent and -independent pathways. J Biol Chem 267:6725–6735
    Chao W, Olson MS (1993) Platelet-activating factor: receptors and signaltransduction. Biochem J 292:617–629
    Cunha FQ, Boukili MA, Motta JIB, Vargaftig BB, Ferreira SH (1993) Blockade by fenspiride of endotoxin-induced neutrophil migration in the rat. Eur J Pharmacol 238:47–52
    Debek W, Chyczewski L, Makarewicz M (1998) Platelet-activating factor receptor-antagonist (BN 52021) stabilizes the oxidative-antioxidative balance and attenuates the morphological changes in the gastrointestinal tract in experimental hemorrhagic shock. Exp Toxicol Pathol 50:19–25
    Duncan M, Grant G (2003) Oral and intestinal mucositis—causes and possible treatments. Aliment Pharmacol Ther 18:853–874
    Dupont L, Germain G, Dideberg O (1986) Crystal and molecular structure of BN 52021, a PAF-acether antagonist. Comparison with the conformation of Kadsurenone and related compounds. Pharmacol Res Commun 18:25–32
    Farrell CL, Bready JV, Rex KL, Chen JN, DiPalma CR, Whitcomb KL, Yin S, Hill DC, Wiemann B, Starnes CO, Havill AM, Lu ZN, Aukerman SL, Pierce GF, Thomason A, Potten CS, Ulich TR, Lacey DL (1998) Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res 58:933–939
    Ferreira MA, Barcelos LS, Teixeira MM, Bakhle YS, Andrade SP (2007) Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF). Life Sci 81:210–217
    Hotchkiss RS, Chang KC, Swanson PE, Tinsley KW, Hui JJ, Klender P, Xanthoudakis S, Roy S, Black C, Grimm E, Aspiotis R, Han Y, Nicholson DW, Karl IE (2000) Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat Immunol 1:496–501
    Hsueh W, Caplan MS, Qu XW, Tan XD, De Plaen IG, Gonzalez-Crussi F (2003) Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 6:6–23
    Hsueh W, Gonzalez-Crussi F, Arroyave JL (1987) Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. FASEB J 1:403–405
    Huang TY, Chu HC, Lin YL, Ho WH, Hou HS, Chao YC, Liao CL (2009) Minocycline attenuates 5-fluorouracil-induced small intestinal mucositis in mouse model. Biochem Biophys Res Commun 389:634–639
    Ishii S, Kuwaki T, Nagase T, Maki K, Tashiro F, Sunaga S, Cao WH, Kume K, Fukuchi Y, Ikuta K, Miyazaki J, Kumada M, Shimizu T (1988) Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J Exp Med 187:1779–1788
    Kuijpers TW, Van Den Berg JM, Tool AT, Roos D (2001) The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase. Clin Exp Immunol 123:412–420
    Liu SX, Tian R, Baskind H, Hsueh W, De Plaen IG (2009) Platelet-activating factor induces the processing of nuclear factor-kappaB p105 into p50, which mediates acute bowel injury in mice. Am J Physiol Gastrointest Liver Physiol 297:G76–G81
    Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, Keefe DM (2009) Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered? Cancer Chemother Pharmacol 63:239–251
    Longley DB, Harkin D, Johnston PG (2003) 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3:330–338
    Lu J, Caplan MS, Li D, Jilling T (2008) Polyunsaturated fatty acids block platelet-activating factor-induced phosphatidylinositol 3 kinase/Akt-mediated apoptosis in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 294:G1181–G1190
    Meenan J, Grool TA, Hommes DW, Dijkhuizen S, Ten Kate FJ, Wood M, Whittaker M, Tytgat GN, Van Deventer SJ (1996) Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis. Eur J Gastroenterol Hepatol 8:569–573
    Melo ML, Brito GA, Soares RC, Carvalho SB, Silva JV, Soares PM, Vale ML, Souza MH, Cunha FQ, Ribeiro RA (2008) Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide. Cancer Chemother Pharmacol 61:775–784
    Merendino N, Dwinell MB, Varki N, Eckmann L, Kagnoff MF (1999) Human intestinal epithelial cells express receptors for platelet-activating factor. Am J Physiol Gastrointest Liver Physiol 277:G810–G818
    Moreno SE, Alves-Filho JC, Rios-Santos F, Silva JS, Ferreira SH, Cunha FQ, Teixeira MM (2006) Signaling via platelet-activating factor receptors accounts for the impairment of neutrophil migration in polymicrobial sepsis. J Immunol 177:1264–1271
    Muguruma K, Gray PW, Tjoelker LW, Johnston JM (1997) The central role of PAF in necrotizing enterocolitis development. Adv Exp Med Biol 407:379–382
    Orazi A, Du X, Yang Z, Kashai M, Williams DA (1996) Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest 75:33–42
    Pritchard DM, Jackman A, Potten CS, Hickman JA (1998) Chemically-induced apoptosis: p21 and p53 as determinants of enterotoxin activity. Toxicol Lett 102–103:19–27
    Qu X, Huang L, Burthart T, Crawford SE, Caplan MS, Hsueh W (1996) Endotoxin induces PAF production in the rat ileum: quantitation of tissue PAF by an improved method. Prostaglandins 51:249–262
    Ribeiro RA, Flores CA, Cunha FQ, Ferreira SH (1991) IL-8 causes in vivo neutrophil migration by a cell-dependent mechanism. Immunology 73:472–477
    Safieh-Garabedian B, Poole S, Allchorne A, Winter J, Woolf CJ (1995) Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol 115:1265–1275
    Soares PM, Mota JM, Gomes AS, Oliveira RB, Assreuy AM, Brito GA, Santos AA, Ribeiro RA, Souza MH (2008) Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Cancer Chemother Pharmacol 63:91–98
    Sonis ST (1998) Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced tomato toxicity. Oral Oncol 34:39–43
    Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100:1995–2025
    Souza DG, Fagundes CT, Sousa LP, Amaral FA, Souza RS, Souza AL, Kroon EG, Sachs D, Cunha FQ, Bukin E, Atrasheuskaya A, Ignatyev G, Teixeira MM (2009) Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection. Proc Natl Acad Sci USA 106:14138–14143
    Souza DG, Pinho V, Soares AC, Shimizu T, Ishii S, Teixeira MM (2003) Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment. Br J Pharmacol 139:733–740
    Strater J, Wellisch I, Riedl S, Walczak H, Koretz K, Tandara A, Krammer PH, Moller P (1997) CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology 113:160
    Sun XM, Hsueh W (1988) Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. J Clin Invest 81:1328–1331
    Venkatesha RT, Ahamed J, Nuesch C, Zaidi AK, Ali H (2004) Platelet-activating factor induced chemokine gene expression requires NF-kappaB activation and Ca2þ/calcineurin signaling pathways. Inhibition by receptor phosphorylation and beta-arrestin recruitment. J Biol Chem 279:44606–44612